BioCentury
ARTICLE | Financial News

Mesoblast proposes follow-on

November 9, 2015 8:00 AM UTC

Mesoblast Ltd. (ASX:MSB; Pink:MBLTY), Melbourne, Australia Business: Gene/Cell therapy Date announced: 2015-11-02 Type: Follow-on To be raised: Up to $79.9 million Shares: 5.7 million Price Prior: A$3...